Azurity Pharmaceuticals Acquires Slayback Pharma
27 Sep 2023 //
PR NEWSWIRE
Slayback`s Generic Baclofen Receives Approval in the U.S.
08 Jun 2023 //
FDA
Slayback`s Generic Brimonidine Tartrate Receives Tentative Approval in U.S.
03 Jan 2023 //
FDA
Slayback`s Generic Formoterol Fumarate Receives Approval in the U.S.
13 Dec 2022 //
FDA
Slayback`s Generic Arformoterol Tartrate Receives Approval in the U.S.
28 Nov 2022 //
FDA
Dr. Reddy`s Laboratories enters into a licensing agreement with Slayback Pharma
30 Jul 2022 //
BUSINESSWIRE
Pfizer Sues Teva, Slayback to Block Copies of Two Xeljanz Doses
16 Feb 2022 //
BLOOMBERGLAW
Slayback Appoints Pete Meyers as Chief Financial Officer
26 Jun 2021 //
PR NEWSWIRE